CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-037020
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
  
Protein Name
 Nitric oxide synthase, endothelial 
Protein Synonyms/Alias
  
Gene Name
 NOS3 
Gene Synonyms/Alias
  
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
567VENLQSSKSTRATILubiquitination[1]
628VAVEQLEKGSPGGPPubiquitination[1, 2]
698PRRYEEWKWFRCPTLubiquitination[2]
829RLHDIESKGLQPTPMubiquitination[2]
879SREPDNPKTYVQDILubiquitination[1, 2, 3]
Reference
 [1] Systematic and quantitative assessment of the ubiquitin-modified proteome.
 Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
 Mol Cell. 2011 Oct 21;44(2):325-40. [PMID: 21906983]
 [2] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [3] Integrated proteomic analysis of post-translational modifications by serial enrichment.
 Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA.
 Nat Methods. 2013 Jul;10(7):634-7. [PMID: 23749302
Functional Description
  
Sequence Annotation
  
Keyword
 Complete proteome; Reference proteome. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 997 AA 
Protein Sequence
MFTYICNHIK YATNRGNLRS AITVFPQRCP GRGDFRIWNS QLVRYAGYRQ QDGSVRGDPA 60
NVEITELCIQ HGWTPGNGRF DVLPLLLQAP DDPPELFLLP PELVLEVPLE HPTLEWFAAL 120
GLRWYALPAV SNMLLEIGGL EFPAAPFSGW YMSTEIGTRN LCDPHRYNIL EDVAVCMDLD 180
TRTTSSLWKD KAAVEINVAV LHSYQLAKVT IVDHHAATAS FMKHLENEQK ARGGCPADWA 240
WIVPPISGSL TPVFHQEMVN YFLSPAFRYQ PDPWKGSAAK GTGITRKKTF KEVANAVKIS 300
ASLMGTVMAK RVKATILYGS ETGRAQSYAQ QLGRLFRKAF DPRVLCMDEY DVVSLEHETL 360
VLVVTSTFGN GDPPENGESF AAALMEMSGP YNSSPRPEQH KSYKIRFNSI SCSDPLVSSW 420
RRKRKESSNT DSAGALGTLR FCVFGLGSRA YPHFCAFARA VDTRLEELGG ERLLQLGQGD 480
ELCGQEEAFR GWAQAAFQAA CETFCVGEDA KAAARDIFSP KRSWKRQRYR LSAQAEGLQL 540
LPGLIHVHRR KMFQATIRSV ENLQSSKSTR ATILVRLDTG GQEGLQYQPG DHIGVCPPNR 600
PGLVEALLSR VEDPPAPTEP VAVEQLEKGS PGGPPPGWVR DPRLPPCTLR QALTFFLDIT 660
SPPSPQLLRL LSTLAEEPRE QQELEALSQD PRRYEEWKWF RCPTLLEVLE QFPSVALPAP 720
LLLTQLPLLQ PRYYSVSSAP STHPGEIHLT VAVLAYRTQD GLGPLHYGVC STWLSQLKPG 780
DPVPCFIRGA PSFRLPPDPS LPCILVGPGT GIAPFRGFWQ ERLHDIESKG LQPTPMTLVF 840
GCRCSQLDHL YRDEVQNAQQ RGVFGRVLTA FSREPDNPKT YVQDILRTEL AAEVHRVLCL 900
ERGHMFVCGD VTMATNVLQT VQRILATEGD MELDEAGDVI GVLRDQQRYH EDIFGLTLRT 960
QEVTSRIRTQ SFSLQERQLR GAVPWAFDPP GSDTNSP 997 
Gene Ontology
 GO:0005737; C:cytoplasm; IEA:Compara.
 GO:0005634; C:nucleus; IEA:Compara.
 GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
 GO:0010181; F:FMN binding; IEA:InterPro.
 GO:0020037; F:heme binding; IEA:InterPro.
 GO:0005506; F:iron ion binding; IEA:InterPro.
 GO:0050661; F:NADP binding; IEA:InterPro.
 GO:0004517; F:nitric-oxide synthase activity; IEA:Compara.
 GO:0001525; P:angiogenesis; IEA:Compara.
 GO:0001974; P:blood vessel remodeling; IEA:Compara.
 GO:0001701; P:in utero embryonic development; IEA:Compara.
 GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Compara.
 GO:0030324; P:lung development; IEA:Compara.
 GO:0051926; P:negative regulation of calcium ion transport; IEA:Compara.
 GO:0008285; P:negative regulation of cell proliferation; IEA:Compara.
 GO:0051346; P:negative regulation of hydrolase activity; IEA:Compara.
 GO:0014740; P:negative regulation of muscle hyperplasia; IEA:Compara.
 GO:0043267; P:negative regulation of potassium ion transport; IEA:Compara.
 GO:0006809; P:nitric oxide biosynthetic process; IEA:Compara.
 GO:0001542; P:ovulation from ovarian follicle; IEA:Compara.
 GO:0045766; P:positive regulation of angiogenesis; IEA:Compara.
 GO:0050880; P:regulation of blood vessel size; IEA:Compara.
 GO:0002028; P:regulation of sodium ion transport; IEA:Compara.
 GO:0003057; P:regulation of the force of heart contraction by chemical signal; IEA:Compara.
 GO:0014806; P:smooth muscle hyperplasia; IEA:Compara. 
Interpro
 IPR003097; FAD-binding_1.
 IPR017927; Fd_Rdtase_FAD-bd.
 IPR001094; Flavdoxin.
 IPR008254; Flavodoxin/NO_synth.
 IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
 IPR023173; NADPH_Cyt_P450_Rdtase_dom3.
 IPR004030; NO_synthase_oxygenase_dom.
 IPR026009; NOS.
 IPR012144; NOS_met.
 IPR001433; OxRdtase_FAD/NAD-bd.
 IPR017938; Riboflavin_synthase-like_b-brl. 
Pfam
 PF00667; FAD_binding_1
 PF00258; Flavodoxin_1
 PF00175; NAD_binding_1
 PF02898; NO_synthase 
SMART
  
PROSITE
 PS51384; FAD_FR
 PS50902; FLAVODOXIN_LIKE 
PRINTS
 PR00369; FLAVODOXIN.
 PR00371; FPNCR.